The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects

Tài liệu liên quan:

• Hypersensitivity to oxaliplatin: Clinical features and risk factors

  6 trang 25 0 0

• Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: A case-control study

  10 trang 20 0 0

• Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: Analysis of diffusing capacity of the lung for carbon monoxide (DLCO) and forced expiratory volume in one second (FEV1)

  9 trang 19 0 0

• Disability-adjusted life years associated with population ageing in China, 1990- 2017

  10 trang 18 0 0

• Efect of periodontal therapy on COPD outcomes: A systematic review

  16 trang 17 0 0

• Development and validation of a nomogram to predict pulmonary function and the presence of chronic obstructive pulmonary disease in a Korean population

  8 trang 15 0 0

• Prevalence, trends, patterns and associations of analgesic use in Germany

  13 trang 15 0 0

• External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)

  9 trang 14 0 0

• Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine

  17 trang 14 0 0

• Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD

  8 trang 14 0 0